An Infantile Misrepresentation

Tylenol lawsuits continue

If you purchased Infants’ Tylenol any time from October 2014 to January 6, 2020, you may be entitled to a few bucks.  Johnson and Johnson received negative backlash following the infamous talcum powder dispute and the company remains under scrutiny due to misrepresented pill bottles.  According to this most recent lawsuit, Johnson and Johnson allegedly advertises on its packaging that their Infants’ Tylenol is specially manufactured to supply a safe dosage for infants.  On the contrary, the concentration of acetaminophen is 160 mg, the same level found in Johnson and Johnson’s Children’s Tylenol.

Despite claims on its packaging, there are no unique differences existing between the Infants’ Tylenol and the Children’s Tylenol. In the eyes of consumers, this is a deceptive business practice.  This is not the first time Johnson and Johnson has become the subject of a Tylenol-related lawsuit. In 1994, a plaintiff accused Johnson and Johnson of negligently failing to warn consumers of the dangerous effects of taking Tylenol with alcohol. The plaintiff required a liver transplant after ingesting the recommended dose of Extra-Strength Tylenol.  Since then, consumers have continued to argue that Johnson and Johnson does not effectively display labels, warning consumers that Tylenol is medically linked to liver failure.

While this current class action lawsuit does not touch on the topic of health effects, it does focus on the company’s lack of accurate or honest packaging.  Johnson and Johnson has agreed to settle and is willing to pay up to $6.3 million in damages.  Those who have purchased the Infants’ Tylenol since 2014 and possess proof of purchase are encouraged to file a claim by April 13, 2020.  The claimants will receive $2.15 per every 1- or 2-ounce bottle of Infants’ Tylenol purchased.  For those who have misplaced their receipts, a maximum of $15.05 will be paid.